Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Akebia Therapeutics, Inc. (NASDAQ: AKBA)
AKBA Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-28.10%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
381.60%
AKBA Stock Analysis
AKBA
PE Ratio:
AKBA
PEG Ratio:
Not Available
AKBA
Forward EPS Growth (12 month):
0.00%
AKBA
PS Ratio:
1.1
AKBA
PSG Ratio:
AKBA
Forward Revenue Growth (12 month):
-23.90%
AKBA Articles
No data was found